Your browser doesn't support javascript.
loading
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Yamamoto, Chihiro; Minakata, Daisuke; Yokoyama, Daizo; Furuki, Shuka; Noguchi, Atsuto; Koyama, Shunsuke; Oyama, Takashi; Murahashi, Rui; Nakashima, Hirotomo; Ikeda, Takashi; Kawaguchi, Shin-Ichiro; Hyodo, Kazuki; Toda, Yumiko; Ito, Shoko; Nagayama, Takashi; Umino, Kento; Morita, Kaoru; Ashizawa, Masahiro; Ueda, Masuzu; Hatano, Kaoru; Sato, Kazuya; Ohmine, Ken; Fujiwara, Shin-Ichiro; Kanda, Yoshinobu.
Afiliação
  • Yamamoto C; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Minakata D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Yokoyama D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Furuki S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Noguchi A; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Koyama S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Oyama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Murahashi R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Nakashima H; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ikeda T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Kawaguchi SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Hyodo K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Toda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ito S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Nagayama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Umino K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Morita K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ashizawa M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ueda M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Sato K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ohmine K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Fujiwara SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan; Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan. Electronic address: ycanda-tky@umin.ac.jp.
Transplant Cell Ther ; 30(1): 118.e1-118.e15, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37802181

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão